Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 January 2022 | Story Charlene Stanley | Photo Supplied
Prof Francis E Smit has been elected as member of the American Association for Thoracic Surgery (AATS), an elite international organisation whose members have made significant contributions to the care and treatment of cardiothoracic disease throughout the world.

Prof Francis E Smit, Head of the Department of Cardiothoracic Surgery, has become only the third person from sub-Saharan Africa to receive the honour of being elected as a member of the American Association for Thoracic Surgery (AATS).

Stringent membership requirements

The AATS is an august international academic organisation founded more than a century ago by the earliest pioneers in the field of thoracic surgery, to which members are elected according to merit. Membership requires sponsorship and referees from senior and active members, followed by an extensive vetting process by the membership committee.  Currently, the association has more than 1 400 active members from 41 countries. Around 30 to 40 new members are accepted annually, of which only 10 to 15 reside outside the USA and Canada. Successful applicants are selected based on an established international leadership record in the field of cardiothoracic surgery, as demonstrated by their commitment to society and institutions, training and education, research and innovation – including peer-reviewed publications, excellence in patient care, and mentorship of the next generation of cardiothoracic surgeons.

"We are extremely proud of this well-deserved international accolade bestowed on Prof Smit,” said Prof Francis Petersen, Rector and Vice-Chancellor. “Not only does it validate the high standard of cardiothoracic training at the UFS, but also our commitment to multi-disciplinary research and internationalisation."  

Benefits of membership

For Prof Smit, the main benefit of membership lies in the fact that it facilitates high-level collaboration with USA-based researchers and companies, which will contribute towards his vision of making the UFS Department of Cardiothoracic Surgery a leading multi-disciplinary research and training unit with national and international collaborators.

Prof Smit is a firm believer in the potential and relevance of South African research. One of his greatest achievements since his appointment at the UFS in 2004, was the establishment of the interdisciplinary Robert WM Frater Cardiovascular Research Centre in 2015. 

The Frater Centre has three divisions, namely clinical research, bio-engineering, and an integrated multi-disciplinary training and education simulation programme, establishing collaborative research and postgraduate training programmes based on a strategy of interdisciplinary, inter-university, national, and international cooperation. 

World-class cardiovascular research at UFS 

The clinical research division – notably the interdisciplinary cardiomyopathy study group – conducts clinical research in adult and paediatric cardiology and cardiothoracic surgery. The bio-engineering division has developed a patented tissue-engineered de-cellularised bovine pericardial patch for use in cardiovascular and other surgical disciplines. A sub-section of this division conducts research in alternative fixation processes of de-cellularised biological tissue, re-cellularisation and organoid generation, as well as in cardiovascular pharmacology. Research is also being conducted on novel heart valve designs, including testing and evaluation in bench and animal models.  A world-class integrated multi-disciplinary simulation-based education and training system has been developed, catering for African needs and programmes.

News Archive

Researcher part of project aimed at producing third-generation biofuels from microalgae in Germany
2016-05-09

Description: Novagreen bioreactor  Tags: Novagreen bioreactor

Some of the researchers and technicians among the tubes of the Novagreen bioreactor (Prof Grobbelaar on left)

A researcher from the University of the Free State (UFS), Prof Johan Grobbelaar, was invited to join a group of scientists recently at the Institute for Bio- and Geo-Sciences of the Research Centre Jülich, in Germany, where microalgae are used for lipid (oil) production, and then converted to kerosene for the aviation industry.

The project is probably the first of its kind to address bio-fuel production from microalgae on such a large scale.  

“The potential of algae as a fuel source is undisputed, because it was these photoautotrophic micro-organisms that were fixing sunlight energy into lipids for millions of years, generating the petroleum reserves that modern human civilisation uses today.  However, these reserves are finite, so the challenge is marrying biology with technology to produce economically-competitive fuels without harming the environment and compromising our food security.  The fundamental ability that microalgae have to produce energy-rich biomass from CO2, nutrients, and sunlight through photosynthesis for biofuels, is commonly referred to as the Third-Generation Biofuels (3G),” said Prof Grobbelaar.

The key compounds used for bio-diesel and kerosene production are the lipids and, more particularly, the triacylglyserols commonly referred to as TAGs.  These lipids, once extracted, need to be trans-esterified for biodiesel, while a further “cracking” step is required to produce kerosene.  Microalgae can store energy as lipids and/or carbohydrates. However, for biofuels, microalgae with high TAG contents are required.  A number of such algae have been isolated, and lipid contents of up to 60% have been achieved.

According to Prof Grobbelaar, the challenge is large-scale, high-volume production, since it is easy to manipulate growth conditions in the laboratory for experimental purposes.  

The AUFWIND project (AUFWIND, a German term for up-current, or new impetus) in Germany consists of three different commercially-available photobioreactor types, which are being compared for lipid production.

Description: Lipid rich chlorella Tags: Lipid rich chlorella

Manipulated Chlorella with high lipid contents (yellow) in the Novagreen bioreactor

The photobioreactors each occupies 500 m2 of land surface area, are situated next to one another, and can be monitored continuously.  The three systems are from Novagreen, IGV, and Phytolutions.  The Novagreen photobioreactor is housed in a glass house, and consist of interconnected vertical plastic tubes roughly 150 mm in diameter. The Phytolutions system is outdoors, and consists of curtains of vertical plastic tubes with a diameter of about 90 mm.  The most ambitious photobioreactor is from IGV, and consists of horizontally-layered nets housed in a plastic growth hall, where the algae are sprayed over the nets, and allowed to grow while dripping from one net to the next.

Prof Grobbelaar’s main task was to manipulate growth conditions in such a way that the microalgae converted their stored energy into lipids, and to establish protocols to run the various photobioreactors. This was accomplished in just over two months of intensive experimentation, and included modifications to the designs of the photobioreactors, the microalgal strain selection, and the replacement of the nutrient broth with a so-called balanced one.

Prof Grobbelaar has no illusions regarding the economic feasibility of the project.  However, with continued research, optimisation, and utilisation of waste resources, it is highly likely that the first long-haul flights using microalgal-derived kerosene will be possible in the not-too-distant future.

Prof Grobbelaar from the Department of Plant Sciences, although partly retired, still serves on the editorial boards of several journals. He is also involved with the examining of PhDs, many of them from abroad.  In addition, he assisted the Technology Innovation Agency of South Africa in the formulation of an algae-biotechnology and training centre.  “The chances are good that such a centre will be established in Upington, in the Northern Cape,” Prof Grobbelaar said.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept